S. aureus endocarditis: Clinical aspects and experimental approaches

Area of Science:

• Cardiology
• Infectious Diseases
• Microbiology

Background:

• Infective endocarditis (IE) is a severe condition with a high mortality rate, often caused by bacterial bloodstream infections.
• Historically linked to streptococci in younger patients, IE now increasingly involves Staphylococcus aureus, particularly in older, immunocompromised, or device-bearing individuals.
• Shifts in patient demographics and the rise of antibiotic resistance have altered the landscape of IE, impacting its pathophysiology and clinical presentation.

Purpose of the Study:

• To review the evolving epidemiology of IE, focusing on the impact of Staphylococcus aureus.
• To discuss pathogenic strategies of S. aureus in IE development and current experimental models.
• To present updated diagnostic imaging and treatment guidelines for S. aureus IE.

Main Methods:

• Literature review of recent studies on IE epidemiology, pathophysiology, and treatment.
• Analysis of S. aureus virulence factors and host immune responses in IE.
• Synthesis of current guidelines for diagnosis and management of S. aureus IE.

Main Results:

• Staphylococcus aureus is a growing cause of IE, associated with increased healthcare exposure and invasive procedures.
• Understanding S. aureus virulence and host responses is crucial for developing new therapies and diagnostics.
• Current guidelines emphasize specific imaging techniques and tailored treatment regimens for S. aureus IE.

Conclusions:

• The changing demographics of IE necessitate a re-evaluation of diagnostic and therapeutic approaches, with a focus on S. aureus.
• Further research into host-pathogen interactions is vital for novel antipathogenic strategies and diagnostic markers.
• Adherence to updated guidelines for imaging and treatment is essential for improving outcomes in S. aureus IE.